Opportunity Information: Apply for RFA EH 09 002

  • The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Program to Expand State Public Health Laboratory Capacity for Newborn Bloodspot Screening (U01)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.064 Laboratory Training, Evaluation, and Quality Assurance Programs.
  • This funding opportunity was created on Jan 21, 2009 and posted on Jan 21, 2009.
  • Applicants must submit their applications by Mar 30, 2009 Letter of Intent Deadline February 19, 2009. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • The funding agency has allocated a total of $1,000,000.00 to eligible and selected applicants.
  • Each selected applicant is eligible to receive up to $500,000.00 in funding.
  • The number of recipients for this funding is limited to 2 candidate(s).
  • Eligible applicants include: City or township governments Native American tribal governments (Federally recognized) Native American tribal organizations (other than Federally recognized tribal governments) State governments Special district governments County governments.
Apply for RFA EH 09 002

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Opportunity Summary:

The CDC funding opportunity titled "Program to Expand State Public Health Laboratory Capacity for Newborn Bloodspot Screening (U01)" (Funding Opportunity Number RFA EH 09 002) is a discretionary cooperative agreement designed to help public health laboratories strengthen and modernize their newborn screening capabilities. The core aim is to support the development and refinement of new laboratory test methods that can be applied to newborn dried bloodspot screening, specifically targeting conditions that are not currently included on the American College of Medical Genetics (ACMG) recommended primary and secondary newborn screening panels. In practical terms, the program is about expanding what state and other governmental public health labs can reliably test for, improving the science and implementation readiness of emerging screening assays, and helping the public health system prepare for future additions to newborn screening programs.

The total estimated funding available for fiscal year 2009 is approximately $1,000,000, with CDC planning to make two awards. The implied budget structure sets an award ceiling of $500,000 per award, aligning with the plan for two recipients to split the overall allocation depending on final award decisions. Because the funding mechanism is a cooperative agreement (U01), recipients should expect substantial involvement from CDC compared with a typical grant. Cooperative agreements generally mean CDC will collaborate with awardees on technical direction, performance expectations, and coordination activities, which fits a program focused on developing and refining laboratory methods that may require standardized approaches, shared validation strategies, and strong quality practices.

Eligible applicants are limited to governmental and certain tribal entities, reflecting the public health laboratory focus of the program. Eligible organizations include state governments, county governments, city or township governments, special district governments, federally recognized tribal governments, and other tribal organizations. There is no cost-sharing or matching requirement, which reduces barriers for public sector laboratories that may not have flexible funds to meet match obligations. The program is listed under CFDA 93.064, which corresponds to CDC laboratory training, evaluation, and quality assurance programs, signaling that beyond pure research, the initiative is closely tied to laboratory quality systems, evaluation, and applied readiness for public health use.

Key dates indicate the opportunity was posted on January 21, 2009, with a letter of intent due February 19, 2009, and a full application closing date of March 30, 2009. The archive date is April 29, 2009, which typically means the opportunity was no longer active after that point for new submissions. CDC anticipated making awards before August 31, 2009, providing a clear timeline from submission to expected funding decisions. For applicants needing help accessing the announcement, CDC provided assistance through the Procurement and Grants Office Technical Information Management Section (PGOTIMS) at 770-488-2700.

Overall, this opportunity is best understood as an applied public health laboratory capacity-building and method-development effort centered on newborn bloodspot screening. It is intended to move potential new screening tests closer to real-world implementation by improving assay methods, performance, and suitability for state public health laboratory workflows, especially for conditions outside the then-current ACMG recommended panels.

Frequently Asked Questions (FAQs)

What is the name of this CDC funding opportunity?

The opportunity is titled "Program to Expand State Public Health Laboratory Capacity for Newborn Bloodspot Screening (U01)." The Funding Opportunity Number is RFA EH 09 002.

What type of funding mechanism is this?

This is a discretionary cooperative agreement (U01). A cooperative agreement typically involves substantial CDC involvement compared with a standard grant, including collaboration on technical direction, coordination, and performance expectations.

What is the main purpose of the program?

The core purpose is to help public health laboratories strengthen and modernize newborn screening capabilities by supporting the development and refinement of laboratory test methods that can be applied to newborn dried bloodspot screening.

What kinds of screening tests is this program focused on?

The focus is on developing and refining new laboratory test methods for conditions that are not currently included on the American College of Medical Genetics (ACMG) recommended primary and secondary newborn screening panels.

Is this opportunity about research, implementation, or both?

Based on the description, it is an applied public health laboratory capacity-building and method-development effort. It emphasizes improving assay methods, performance, and implementation readiness for public health laboratory workflows rather than research alone.

How does CDC expect to be involved with awardees?

Because this is a U01 cooperative agreement, CDC expects substantial involvement. The description suggests collaboration may include technical direction, performance expectations, coordination activities, and support for standardized approaches, shared validation strategies, and strong quality practices.

Who is eligible to apply?

Eligible applicants are limited to governmental and certain tribal entities. Eligible organizations include state governments, county governments, city or township governments, special district governments, federally recognized tribal governments, and other tribal organizations.

Are non-governmental organizations eligible to apply?

The eligibility list provided is limited to governmental and certain tribal entities. No other categories are identified in the provided information.

Is there a cost-sharing or matching requirement?

No. The opportunity states there is no cost-sharing or matching requirement.

How much funding is available?

The total estimated funding available for fiscal year 2009 is approximately $1,000,000.

How many awards does CDC plan to make?

CDC planned to make two awards.

What is the expected award size or ceiling?

The implied structure indicates an award ceiling of $500,000 per award, consistent with the plan to make two awards from an estimated total of $1,000,000.

What is the CFDA number for this program and what does it indicate?

The program is listed under CFDA 93.064. The description ties this to CDC laboratory training, evaluation, and quality assurance programs, indicating an emphasis on quality systems, evaluation, and applied readiness for public health laboratory use.

What is being screened and what specimen type is referenced?

The opportunity centers on newborn bloodspot screening, specifically mentioning newborn dried bloodspot screening as the application context for new or refined laboratory test methods.

What is the timeline for key submission dates?

The opportunity was posted on January 21, 2009. The letter of intent was due February 19, 2009. The full application closing date was March 30, 2009.

What does the archive date mean for this opportunity?

The archive date is April 29, 2009, which typically indicates the opportunity was no longer active for new submissions after that point.

When did CDC expect to make award decisions?

CDC anticipated making awards before August 31, 2009.

What kind of outcomes is this program trying to support?

The program is intended to move potential new screening tests closer to real-world implementation by improving assay methods, performance, and suitability for state public health laboratory workflows, and by helping the public health system prepare for future additions to newborn screening programs.

How does this opportunity relate to future newborn screening expansion?

It is framed as a way to help public health laboratories prepare for future additions to newborn screening programs by improving the science and implementation readiness of emerging screening assays, especially for conditions outside the then-current ACMG recommended panels.

Where can applicants get help accessing the announcement?

CDC provided assistance through the Procurement and Grants Office Technical Information Management Section (PGOTIMS) at 770-488-2700.

Browse more opportunities from the same agency: Centers for Disease Control and Prevention

Browse more opportunities from the same category: Health

Next opportunity: Program to Enhance State Public Health Laboratory Capacity for Newborn Bloodspot Screening (U01)

Previous opportunity: DOD Breast Cancer Postdoctoral Fellowship Award

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA EH 09 002

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (RFA EH 09 002) also looked into and applied for these:

Funding Opportunity
Program to Enhance State Public Health Laboratory Capacity for Newborn Bloodspot Screening (U01) Apply for RFA EH 09 003

Funding Number: RFA EH 09 003
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $150,000
Expanding the Chemical Space for Carbohydrates (R01) Apply for RFA GM 09 005

Funding Number: RFA GM 09 005
Agency: National Institutes of Health
Category: Health
Funding Amount: $250,000
Mechanism of Alcohol Induced Organ Damage (R01) Apply for RFA AA 09 006

Funding Number: RFA AA 09 006
Agency: National Institutes of Health
Category: Health
Funding Amount: $250,000
Medical Monitoring Project (MMP) Apply for CDC RFA PS09 937

Funding Number: CDC RFA PS09 937
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $930,000
EMSC Network Development Demonstration Project (NDDP) Central Data Management and Coordinating Center (CDMCC) Apply for HRSA 09 152

Funding Number: HRSA 09 152
Agency: Health Resources and Services Administration
Category: Health
Funding Amount: $1,600,000
The NEI Mentored Clinical Scientist Development Program Award (K12) Apply for PAR 09 083

Funding Number: PAR 09 083
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Accelerating Development of Methods for the Study of Complex Patients (R21) Apply for RFA HS 09 002

Funding Number: RFA HS 09 002
Agency: Agency for Health Care Research and Quality
Category: Health
Funding Amount: $300,000
Mentored Clinical Scientist Research Career Development Award (K08) Apply for PAR 09 085

Funding Number: PAR 09 085
Agency: Agency for Health Care Research and Quality
Category: Health
Funding Amount: Case Dependent
Independent Scientist Award (K02) Apply for PAR 09 086

Funding Number: PAR 09 086
Agency: Agency for Health Care Research and Quality
Category: Health
Funding Amount: Case Dependent
Mentored Research Scientist Research Career Development Award (K01) Apply for PAR 09 087

Funding Number: PAR 09 087
Agency: Agency for Health Care Research and Quality
Category: Health
Funding Amount: Case Dependent
Dietary Supplement Research Centers Botanicals (P50) Apply for RFA OD 09 001

Funding Number: RFA OD 09 001
Agency: National Institutes of Health
Category: Health
Funding Amount: $1,000,000
Tools to Mitigate and Understand the Mental Health Effects of National Disasters SBIR R43/R44 Apply for PA 06 335

Funding Number: PA 06 335
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Tools to Mitigate and Understand the Mental Health Effects of National Disasters STTR R41/R42 Apply for PA 06 336

Funding Number: PA 06 336
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Novel Tools for Investigating Brain derived GPCRs in Mental Health Research (STTR R41/R42) Apply for PA 06 374

Funding Number: PA 06 374
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Novel Tools for Investigating Brain derived GPCRs in Mental Health Research (SBIR R43/R44) Apply for PA 06 375

Funding Number: PA 06 375
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Longitudinal Surveys of the Elderly SBIR Initiative (R43/R44) Apply for PA 06 465

Funding Number: PA 06 465
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Longitudinal Surveys of the Elderly STTR Initiative (R41/R42) Apply for PA 06 464

Funding Number: PA 06 464
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Technological Enhancements for Surveys of the Elderly STTR (R41/R42) Initiative Apply for PA 06 472

Funding Number: PA 06 472
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Technological Enhancements for Surveys of the Elderly SBIR (R43/R44) Initiative Apply for PA 06 471

Funding Number: PA 06 471
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
New Technology to Screen for Mild Hearing Loss in Children (SBIR R43/R44) Apply for PA 06 546

Funding Number: PA 06 546
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

USGrants.org applicant portal membership

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA EH 09 002", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.